Jak Knowles

Jak Knowles

Company: Affini-T Therapeutics

Job title: Chief Executive Officer


Workshop B: Armouring T-Cells to Overcome the Tumour Microenvironment for TCR Therapies in Solid Tumours 12:00 pm

Overview of different armouring strategies Immune Fusion Proteins (IFPs): PD-1/CD28, Fas/CD28, Fas/4-1BB Switch receptors: TGF-β/IL-2R, GM-CSF/IL-2R Epigenetic modificationRead more

day: Workshop - Track A - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.